Predicting glaucoma progression using deep learning framework guided by generative algorithm.

Journal: Scientific reports
PMID:

Abstract

Glaucoma is a slowly progressing optic neuropathy that may eventually lead to blindness. To help patients receive customized treatment, predicting how quickly the disease will progress is important. Structural assessment using optical coherence tomography (OCT) can be used to visualize glaucomatous optic nerve and retinal damage, while functional visual field (VF) tests can be used to measure the extent of vision loss. However, VF testing is patient-dependent and highly inconsistent, making it difficult to track glaucoma progression. In this work, we developed a multimodal deep learning model comprising a convolutional neural network (CNN) and a long short-term memory (LSTM) network, for glaucoma progression prediction. We used OCT images, VF values, demographic and clinical data of 86 glaucoma patients with five visits over 12 months. The proposed method was used to predict VF changes 12 months after the first visit by combining past multimodal inputs with synthesized future images generated using generative adversarial network (GAN). The patients were classified into two classes based on their VF mean deviation (MD) decline: slow progressors (< 3 dB) and fast progressors (> 3 dB). We showed that our generative model-based novel approach can achieve the best AUC of 0.83 for predicting the progression 6 months earlier. Further, the use of synthetic future images enabled the model to accurately predict the vision loss even earlier (9 months earlier) with an AUC of 0.81, compared to using only structural (AUC = 0.68) or only functional measures (AUC = 0.72). This study provides valuable insights into the potential of using synthetic follow-up OCT images for early detection of glaucoma progression.

Authors

  • Shaista Hussain
    School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore 639798.
  • Jacqueline Chua
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
  • Damon Wong
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
  • Justin Lo
    Department of Electrical, Computer and Biomedical Engineering, Faculty of Engineering and Architectural Science, Ryerson University, Toronto, ON M5B 2K3, Canada.
  • Aiste Kadziauskiene
    Clinic of Ears, Nose, Throat and Eye Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University (A.K.), Vilnius, Lithuania; Center of Eye diseases, Vilnius University Hospital Santaros Klinikos (A.K.), Vilnius, Lithuania.
  • Rimvydas Asoklis
    Clinic of Ears, Nose, Throat and Eye Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • George Barbastathis
    Singapore-MIT Alliance for Research and Technology (F.A.B., G.B.), Singapore; Department of Mechanical Engineering, Massachusetts Institute of Technology (G.B.), Cambridge, Massachusetts, USA.
  • Leopold Schmetterer
    Singapore Eye Research Institute, Singapore National Eye Center, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
  • Liu Yong
    Institute of Agricultural Information Science and Technology, Shanghai Academy of Agricultural Sciences, Shanghai, China.